| 标题 |
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Infectious Diseases 作者:Zhiqiang Song; Liya Zhou; Liya Zhou; Weihong Wang; Cheng Lan; et al 出版日期:2025-09-11 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)